medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2016, Number 3

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2016; 14 (3)

Photodynamic Therapy Combined with Hyaluronic Acid in Rejuvenating the Neckline: Study of 17 Cases

Amselem M

Language: Spanish
References: 31
Page: 191-198
PDF size: 181.10 Kb.


ABSTRACT

Background: Photodynamic therapy (PDT) is a treatment indicated for the management of non-melanoma skin cancer. Recently, it has taken a more active role in skin rejuvenation. Hyaluronic acid (HA) remains the most natural element and its injection, the procedure most frequently applied in microinjection, for comprehensive skin revitalization.
Objectives: Demonstrate the effectiveness of the combination of PDT + HA in rejuvenating the neckline, evaluating parameters such as elasticity, age spots, fine wrinkles and radiance.
Materials and methods: A series of 17 patients were evaluated, divided into three study arms: only PDT, only HA and PDT + HA (combined group). A visit treatment for the PDT group isolated and three treatment sessions for the other two groups was performed with a single session of PDT and three ha (one injection every 15 days). In the combined group, in the first session both therapies were performed. The final evaluation was carried out one month after the last session.
Results: Better results were observed in the combined therapy group and a differential improvement in the four parameters evaluated in the three groups in general, but more statistical significance in the combination therapy arm.
Conclusions: The combination of PDT + hyaluronic acid injections, technique, called Photovital in this study, is simple and safe atraumatic and effective in rejuvenating the neckline, as stain method, brightness, elasticity and fine wrinkles refers.


REFERENCES

  1. Gilaberte Y. Terapia fotodinámica. Madrid: Aula Médica; 2008.

  2. Horn M, Wolf P, Wulf HC et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003; 149(6): 1242-9.

  3. Vinciullo C, Elliott T, Francis D et al. Photodynamic therapy with topical methyl aminolaevulinate for “difficult-to-treat” basal cell carcinoma. Br J Dermatol 2005; 152(4): 765-72.

  4. Basset-Seguin N, Ibbotson SH, Emtestam L et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 2008; 18(5): 547-53.

  5. Rhodes LE, De Rie M, Enström Y et al. Photodynamic therapy using topical methyl aminolevulinate vs. surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004; 140(1): 17-23.

  6. Foley P, Freeman M, Menter A et al. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. Int J Dermatol 2009; 48(11): 1236-45.

  7. Braathen L, Paredes B, Frohlich K et al. A dose finding study of photodynamic therapy (pdt) with Metvix in patients in actinic keratosis (ak). J Eur Acad DErmatol Venereol 2000; 14 (Suppl.): 1-38.

  8. Szeimies RM, Karrer S, Radakovic-Fijan S et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002; 47(2): 258-62.

  9. Freeman M, Vinciullo C, Francis D et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003; 14(2): 99-106.

  10. Pariser DM, Lowe NJ, Stewart DM et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003; 48(2): 227-32.

  11. Tarstedt M, Rosdahl I, Berne B et al. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-pdt in actinic keratosis of the face and scalp. Acta Derm Venereol 2005; 85(5): 424-8.

  12. Ruiz-Rodríguez R, López L, Candelas D, Pedraz J. Photorejuvenation using topical 5-methyl aminolevulinate and red light. J Drugs Dermatol 2008; 7(7): 633-7.

  13. Pedraz J, Ruiz-Rodríguez R. Rejuvenecimiento con terapia fotodinámica. La Piel 2008; 3(3): 146-54.

  14. Issa MC, Piñeiro-Maceira J, Vieira MT et al. Photorejuvenation with topical methyl aminolevulinate and red light: a randomized, prospective, clinical, histopathologic, and morphometric study. Dermatol Surg 2010; 36(1): 39-48.

  15. Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Br J Dermatol 2006; 154(5): 969-76.

  16. Bissonnette R, Maari C, Nigen S et al. Photodynamic therapy with methylaminolevulinate 80 mg/g without occlusion improves acne vulgaris. J Drugs Dermatol 2010; 9(11): 1347-52.

  17. Redondo P, Sánchez Viera M, Terapia fotodinámica. Madrid: Aula Médica; 2008.

  18. Gaál M, Otrosinka S, Baltás E et al. Photodynamic therapy of nonmelanoma skin cancer with methyl aminolaevulinate is associated with less pain than with aminolaevulinic acid. Acta Derm Venereol 2012; 92(2): 173-5.

  19. Gholam P, Weberschock T, Denk K, Enk A. Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis. Dermatology 2011; 222(4): 358-62.

  20. Matarasso SL. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr Surg 2006; 117 (Suppl.): 3-34.

  21. Williams S. Changes in skin physiology and clinical appearance after microdroplet placement of hyaluronic acid in aging hands. Journal of Cosmetic Dermatology 2009; 8: 216-25.

  22. Kerscher M, Bayrhammer J, Reuther T. Rejuvenating influence of a stabilized hyaluronic acid-based gel of non animal origin on facial skin aging. Dermatol Surg 2008; 34(5): 720-6.

  23. Distante F, Pagani V, Vonfigli A. Rejuvenating the skin of the upper arm. Dermatol Surg 2009; 35: 389-94.

  24. Ribé A, Ribé N. Neck skin rejuvenation: histological and clinical changes after combined therapy with a fractional non-ablative laser and stabilized hyaluronic acid-based gel of non-animal origin. Journal of Cosmetic and Laser Therapy 2011; 13: 154-61.

  25. Reuther T. Effects of a three-session skin rejuvenation treatment using stabilized hyaluronic acid-based gel of non-animal origin on skin elasticity: a pilot study. Arch Dermatol Res 2010; 302(1): 37-45.

  26. Roberts WE. Skin type classification systems old and new. Dermatol Clin 2009; 27(4): 529-33.

  27. Kwon HH, Moon KR, Park SY et al. Daylight photodynamic therapy with 1.5% 3-butenyl 5-aminolevulinate gel as convenient, effective and safe therapy in acne treatment: a double-blind randomized controlled trial. J Dermatol 2016; 43(5): 515-21.

  28. Pariser DM, Eichenfield LF, Bukhalo M, Waterman G, Jarratt M, pdt Study Group. Photodynamic therapy with 80 mg/g methyl aminolaevulinate for severe facial acne vulgaris: a randomised vehicle-controlled study. Br J Dermatol 2016; 174(4): 770-7.

  29. Szeimies RM, Lischner S, Philipp-Dormston W et al. Photodynamic therapy for skin rejuvenation: treatment options-results of a consensus conference of an expert group for aesthetic photodynamic therapy. J Dtsch Dermatol Ges 2013; 11(7): 632-6.

  30. Philipp-Dormston WG, Karrer S, Petering H et al. Daylight pdt with mal current data and practical recommendations of an expert panel. J Dtsch Dermatol Ges 2015; 13(12): 1240-9.

  31. Lane KL, Hovenic W, Ball K, Zachary CB. Daylight photodynamic therapy: the Southern California experience. Lasers Surg Med 2015; 47(2): 168-72.




2020     |     www.medigraphic.com